Who Paid My Doc
Linq II
Device Cardiac Diagnostics and Monitoring
PDI 00763000060374
General payments
$1,573,588
Research payments
$662,682
Through program year 2025, $1,573,588 in general payments and $662,682 in research payments were reported against Linq II (Cardiac Diagnostics and Monitoring).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $326,961 | 6,947 |
| 2024 | General | $427,982 | 7,425 |
| 2024 | Research | $95,497 | 17 |
| 2023 | General | $392,396 | 8,176 |
| 2023 | Research | $446,602 | 23 |
| 2022 | General | $298,592 | 7,968 |
| 2022 | Research | $98,848 | 8 |
| 2021 | General | $127,657 | 3,701 |
| 2021 | Research | $21,735 | 2 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 75 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
34,217 general · 50 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.